Theresa Greco serves as Chief Commercial Officer at OptimizeRx Corp., a leading digital health platform delivering patient engagement and adherence solutions to pharmaceutical companies. With over 25 years of experience in the healthcare and life sciences industries, she brings a proven track record of driving commercial excellence, revenue growth, and strategic innovation. In her role, Greco spearheads the company's go-to-market strategies, sales operations, and customer partnerships, leveraging data-driven insights to enhance OptimizeRx's portfolio of HIPAA-compliant messaging and support services. Prior to joining OptimizeRx in 2021, Greco held senior leadership positions at Syneos Health, where she was Senior Vice President of Commercial Operations, managing multi-billion-dollar portfolios across therapeutic areas and leading high-performing teams to exceed revenue targets by double digits. Her earlier career included key roles at IQVIA and inVentiv Health (now part of Syneos), focusing on sales leadership, market access, and business development. Notable achievements include launching blockbuster products, optimizing field force effectiveness, and pioneering digital commercialization models that accelerated market penetration. Under Greco's stewardship at OptimizeRx, the company has expanded its commercial footprint, forging strategic alliances with top pharma brands and achieving record adoption of its digital health solutions. Her expertise in aligning commercial strategies with evolving regulatory and technological landscapes has positioned OptimizeRx for sustained growth, empowering better patient outcomes through personalized, real-time communications.